// App-Quantinova.ai

e21028 : Antibody-independent ApoStream technology isolates folate receptor alpha (FRA)positive circulating tumor cells from blood of non-small cell lung adenocarcinoma patients.

Researchers

Presenter

  • Darren W. Davis

Principal Investigators

  • Christopher Neal

  • Vishal Gupta

  • Vladislava O. Melnikova

  • Jacky Woo

  • Elizabeth Brooke Somers

  • Daniel O'Shannessy

Medical Centers

  • ApoCell, Inc., Houston, TX

Locations

  • United States

Companies

  • Morphotek, Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lung Cancer

  • Non Small Cell Lung cancer

Biomarkers

  • Circulating tumor cells

  • Cluster of differentiation 45

  • Folate Receptor 1

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A